A newly identified regimen resulted in tumor regression and improved survival, according to a Rutgers study.
Research & Innovation
Last week, Rutgers’ Office for Research announced a new, unified patent policy that was approved and became effective retroactive to July 1, 2021. The Patent Policy was a collaborative effort between University leadership, faculty, staff, and union representatives. It will enhance efforts to support entrepreneurship and expand the innovation ecosystem at Rutgers.
Stories
Rutgers, The State University of New Jersey, has earned prestigious accreditation from the Association for the Accreditation of Human Research Protection Programs (AAHRPP) for the first time. Through this coveted certification, Rutgers Human Research Protection Program (HRPP) and Institutional Review Board (IRB) join the elite ranks of University Human Research Protection programs.
Millennials face a greater risk of ischemic stroke death than Generation X, according to a Rutgers study.
Rutgers Office for Research’s Innovation Ventures has executed an exclusive license agreement between the university and Sauvie BiKE, LLC, a subsidiary of Sauvie Inc., to develop and commercialize a bi-specific natural killer cell engager technology in the field of oncology.
Rutgers researchers hope their genome-assembly tool will spur the development of new treatments for bacterial infections.